Loading...
Loading...
Among the 3 tracked institutional investors we monitor, ONCY (ONCOLYTICS BIOTECH INC) is held with a combined value of $625.37K across 736,776 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $607.60K (0.00% of their portfolio). RENAISSANCE TECHNOLOGIES LLC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$625.37K
Total Shares Held
736,776
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $607.60K | 0.00% | New |
| 2 | CITADEL ADVISORS LLC | $15.22K | 0.00% | +0.0% |
| 3 | BlackRock, Inc. | $2.55K | 0.00% | - |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of ONCY with a position worth $607.60K, representing 0.00% of their portfolio. In total, 3 institutional investors hold ONCY with a combined value of $625.37K.
In the most recent quarter, 1 fund opened a new position in ONCY. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $625.37K worth of ONCY stock across 3 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $607.60K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ONCY, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ONCY positions.